FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3114204300> ?p ?o ?g. }

• W3114204300 abstract "ABSTRACT Background To study the efficacy of oral clarithromycin in moderate COVID-19. Methods An open-label non-randomized trial in 90 patients with COVID-19 of moderate severity was conducted between May and October 2020. The primary endpoint was defined at the end-of-treatment (EOT) as no need for hospital re-admission and no progression into lower respiratory tract infection (LRTI) for patients with upper respiratory tract infection; and as at least 50% decrease of the respiratory symptoms score the without progression into severe respiratory failure (SRF) for patients with LRTI. Viral load, biomarkers, the function of mononuclear cells, and safety were assessed. Results The primary endpoint was attained in 86.7% of patients treated with clarithromycin (95% CIs 78.1-92.2%); this was 91.7% and 81.4% among patients starting clarithromycin the first 5 days from symptoms onset or later (odds ratio after multivariate analysis 6.62; p: 0.030). The responses were better for patients infected by non-B1.1 variants. Clarithromycin use was associated with decreases in circulating C-reactive protein, tumour necrosis factor-alpha and interleukin (IL)-6; by increase of Th1 to Th2 mononuclear responses; and by suppression of SARS-CoV-2 viral load. No safety concerns were reported. Conclusions Early clarithromycin treatment provides most of clinical improvement in moderate COVID-19 ( Trial Registration: ClinicalTrials.gov, NCT04398004 )" @default.
• W3114204300 created "2021-01-05" @default.
• W3114204300 creator A5001026149 @default.
• W3114204300 creator A5001044836 @default.
• W3114204300 creator A5001327948 @default.
• W3114204300 creator A5003002981 @default.
• W3114204300 creator A5003138550 @default.
• W3114204300 creator A5011235996 @default.
• W3114204300 creator A5012060722 @default.
• W3114204300 creator A5015800207 @default.
• W3114204300 creator A5017561150 @default.
• W3114204300 creator A5021152638 @default.
• W3114204300 creator A5030219128 @default.
• W3114204300 creator A5032695551 @default.
• W3114204300 creator A5033874633 @default.
• W3114204300 creator A5034315079 @default.
• W3114204300 creator A5034653331 @default.
• W3114204300 creator A5040839300 @default.
• W3114204300 creator A5042024792 @default.
• W3114204300 creator A5043179726 @default.
• W3114204300 creator A5045949494 @default.
• W3114204300 creator A5052618617 @default.
• W3114204300 creator A5054847244 @default.
• W3114204300 creator A5056134447 @default.
• W3114204300 creator A5056440685 @default.
• W3114204300 creator A5062046607 @default.
• W3114204300 creator A5063788798 @default.
• W3114204300 creator A5063924715 @default.
• W3114204300 creator A5064410569 @default.
• W3114204300 creator A5068481644 @default.
• W3114204300 creator A5079378748 @default.
• W3114204300 creator A5080860642 @default.
• W3114204300 creator A5089813033 @default.
• W3114204300 date "2020-12-26" @default.
• W3114204300 modified "2023-10-18" @default.
• W3114204300 title "Early start of oral clarithromycin is associated with better outcome in COVID-19 of moderate severity: the ACHIEVE open-label trial" @default.
• W3114204300 cites W2014847700 @default.
• W3114204300 cites W2100536943 @default.
• W3114204300 cites W2117036615 @default.
• W3114204300 cites W2130386629 @default.
• W3114204300 cites W2144537497 @default.
• W3114204300 cites W2165484387 @default.
• W3114204300 cites W2170513892 @default.
• W3114204300 cites W2338943353 @default.
• W3114204300 cites W2977322360 @default.
• W3114204300 cites W2988729953 @default.
• W3114204300 cites W3010930696 @default.
• W3114204300 cites W3013893137 @default.
• W3114204300 cites W3016288338 @default.
• W3114204300 cites W3016746341 @default.
• W3114204300 cites W3034858522 @default.
• W3114204300 cites W3043124965 @default.
• W3114204300 cites W3083605260 @default.
• W3114204300 cites W3086049345 @default.
• W3114204300 cites W3092382993 @default.
• W3114204300 cites W3102453076 @default.
• W3114204300 doi "https://doi.org/10.1101/2020.12.22.20248753" @default.
• W3114204300 hasPublicationYear "2020" @default.
• W3114204300 type Work @default.
• W3114204300 sameAs 3114204300 @default.
• W3114204300 citedByCount "3" @default.
• W3114204300 countsByYear W31142043002021 @default.
• W3114204300 countsByYear W31142043002022 @default.
• W3114204300 crossrefType "posted-content" @default.
• W3114204300 hasAuthorship W3114204300A5001026149 @default.
• W3114204300 hasAuthorship W3114204300A5001044836 @default.
• W3114204300 hasAuthorship W3114204300A5001327948 @default.
• W3114204300 hasAuthorship W3114204300A5003002981 @default.
• W3114204300 hasAuthorship W3114204300A5003138550 @default.
• W3114204300 hasAuthorship W3114204300A5011235996 @default.
• W3114204300 hasAuthorship W3114204300A5012060722 @default.
• W3114204300 hasAuthorship W3114204300A5015800207 @default.
• W3114204300 hasAuthorship W3114204300A5017561150 @default.
• W3114204300 hasAuthorship W3114204300A5021152638 @default.
• W3114204300 hasAuthorship W3114204300A5030219128 @default.
• W3114204300 hasAuthorship W3114204300A5032695551 @default.
• W3114204300 hasAuthorship W3114204300A5033874633 @default.
• W3114204300 hasAuthorship W3114204300A5034315079 @default.
• W3114204300 hasAuthorship W3114204300A5034653331 @default.
• W3114204300 hasAuthorship W3114204300A5040839300 @default.
• W3114204300 hasAuthorship W3114204300A5042024792 @default.
• W3114204300 hasAuthorship W3114204300A5043179726 @default.
• W3114204300 hasAuthorship W3114204300A5045949494 @default.
• W3114204300 hasAuthorship W3114204300A5052618617 @default.
• W3114204300 hasAuthorship W3114204300A5054847244 @default.
• W3114204300 hasAuthorship W3114204300A5056134447 @default.
• W3114204300 hasAuthorship W3114204300A5056440685 @default.
• W3114204300 hasAuthorship W3114204300A5062046607 @default.
• W3114204300 hasAuthorship W3114204300A5063788798 @default.
• W3114204300 hasAuthorship W3114204300A5063924715 @default.
• W3114204300 hasAuthorship W3114204300A5064410569 @default.
• W3114204300 hasAuthorship W3114204300A5068481644 @default.
• W3114204300 hasAuthorship W3114204300A5079378748 @default.
• W3114204300 hasAuthorship W3114204300A5080860642 @default.
• W3114204300 hasAuthorship W3114204300A5089813033 @default.
• W3114204300 hasBestOaLocation W31142043001 @default.
• W3114204300 hasConcept C126322002 @default.
• W3114204300 hasConcept C156957248 @default.
• W3114204300 hasConcept C168563851 @default.
• W3114204300 hasConcept C203092338 @default.

• next